Effects of Amino Acid-Functionalized Silver Nanoparticles on Lysozyme Amyloid Fibrillogenesis

[1]  Y. Kuo,et al.  Silver nanoparticle-deposited whey protein isolate amyloid fibrils as catalysts for the reduction of methylene blue. , 2022, International journal of biological macromolecules.

[2]  Steven Sheng-Shih Wang,et al.  Using Sugar-Derived Nanoparticles to Mitigate Amyloid Fibril Formation of Lysozyme , 2022, Journal of the Taiwan Institute of Chemical Engineers.

[3]  D. Huster,et al.  Mechanistic insights into the size-dependent effects of nanoparticles on inhibiting and accelerating amyloid fibril formation. , 2022, Journal of colloid and interface science.

[4]  Jiaojiao Zheng,et al.  Inhibiting protein aggregation with nanomaterials: The underlying mechanisms and impact factors. , 2021, Biochimica et biophysica acta. General subjects.

[5]  B. Meloni,et al.  Arginine and Arginine-Rich Peptides as Modulators of Protein Aggregation and Cytotoxicity Associated With Alzheimer’s Disease , 2021, Frontiers in Molecular Neuroscience.

[6]  J. Tesfaye,et al.  Review on Silver Nanoparticle Synthesis Method, Antibacterial Activity, Drug Delivery Vehicles, and Toxicity Pathways: Recent Advances and Future Aspects , 2021, Journal of Nanomaterials.

[7]  P. Smertenko,et al.  Silver nanoparticles as inhibitors of insulin amyloid formation: A fluorescence study , 2021, Journal of Molecular Liquids.

[8]  V. Uversky,et al.  Mechanisms of amyloid proteins aggregation and their inhibition by antibodies, small molecule inhibitors, nano-particles, and nano-bodies. , 2021, International journal of biological macromolecules.

[9]  A. Dziedzic,et al.  Noncytotoxic silver nanoparticles as a new antimicrobial strategy , 2021, Scientific Reports.

[10]  S. Dutz,et al.  Surface-modified magnetite nanoparticles affect lysozyme amyloid fibrillization. , 2021, Biochimica et biophysica acta. General subjects.

[11]  K. Aguan,et al.  Biocompatible silver nanoparticles: An investigation into their protein binding efficacies, anti-bacterial effects and cell cytotoxicity studies , 2020, Journal of pharmaceutical analysis.

[12]  D. Fedunova,et al.  Investigating the effect of sugar-terminated nanoparticles on amyloid fibrillogenesis of β-lactoglobulin. , 2020, International journal of biological macromolecules.

[13]  M. Delcea,et al.  Biopolymer-coated gold nanoparticles inhibit human insulin amyloid fibrillation , 2020, Scientific Reports.

[14]  Yang Song,et al.  Overcoming blood-brain barrier transport: Advances in nanoparticle-based drug delivery strategies. , 2020, Materials today.

[15]  F. Firouzi,et al.  Predicting the Size of Silver Nanoparticles from Their Optical Properties , 2020, Plasmonics.

[16]  N. Yagi,et al.  Parkinson’s disease is a type of amyloidosis featuring accumulation of amyloid fibrils of α-synuclein , 2019, Proceedings of the National Academy of Sciences.

[17]  R. Mezzenga,et al.  Food protein amyloid fibrils: Origin, structure, formation, characterization, applications and health implications. , 2019, Advances in colloid and interface science.

[18]  S. Paul,et al.  Functionalized gold and silver nanoparticles modulate amyloid fibrillation, defibrillation and cytotoxicity of lysozyme via altering protein surface character , 2019, Applied Surface Science.

[19]  H. Kalhor,et al.  Investigating the effects of amino acid-based surface modification of carbon nanoparticles on the kinetics of insulin amyloid formation. , 2019, Colloids and surfaces. B, Biointerfaces.

[20]  E. Demjén,et al.  Effect of nanoparticles coated with different modifications of dextran on lysozyme amyloid aggregation , 2019, Journal of Magnetism and Magnetic Materials.

[21]  L. Pandey,et al.  Proline functionalized gold nanoparticles modulates lysozyme fibrillation. , 2019, Colloids and surfaces. B, Biointerfaces.

[22]  M. Koneracká,et al.  Destroying activity of glycine coated magnetic nanoparticles on lysozyme, α-lactalbumin, insulin and α-crystallin amyloid fibrils , 2019, Journal of Magnetism and Magnetic Materials.

[23]  Yong Zhu,et al.  Printing Conductive Nanomaterials for Flexible and Stretchable Electronics: A Review of Materials, Processes, and Applications , 2019, Advanced Materials Technologies.

[24]  S. B. Mullani,et al.  Silver nanoparticles as an effective disinfectant: A review , 2018, Materials Science and Engineering: C.

[25]  Shen-Long Tsai,et al.  Examining the effects of dextran-based polymer-coated nanoparticles on amyloid fibrillogenesis of human insulin. , 2018, Colloids and surfaces. B, Biointerfaces.

[26]  Jianqing Gao,et al.  Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances , 2018, Asian journal of pharmaceutical sciences.

[27]  N. Jana,et al.  Antiamyloidogenic Chemical/Biochemical-Based Designed Nanoparticle as Artificial Chaperone for Efficient Inhibition of Protein Aggregation. , 2018, Biomacromolecules.

[28]  N. Jana,et al.  Inhibition of Protein Aggregation by Iron Oxide Nanoparticles Conjugated with Glutamine- and Proline-based Osmolytes , 2018 .

[29]  D. Bevan,et al.  Natural product-based amyloid inhibitors. , 2017, Biochemical pharmacology.

[30]  K. Kar,et al.  Uniform, Polycrystalline, and Thermostable Piperine-Coated Gold Nanoparticles to Target Insulin Fibril Assembly. , 2017, ACS biomaterials science & engineering.

[31]  Josephine W. Wu,et al.  Investigating the effects of erythrosine B on amyloid fibril formation derived from lysozyme. , 2017, International journal of biological macromolecules.

[32]  Szu-Ming Yang,et al.  Examining the inhibitory potency of food additive fast green FCF against amyloid fibrillogenesis under acidic conditions. , 2016, Food & function.

[33]  N. Kishore,et al.  Synergistic Inhibition of Protein Fibrillation by Proline and Sorbitol: Biophysical Investigations , 2016, PloS one.

[34]  Roland Riek,et al.  The activities of amyloids from a structural perspective , 2016, Nature.

[35]  S. Gurunathan,et al.  Molecular Sciences , 2022 .

[36]  K. Kar,et al.  Tyrosine- and tryptophan-coated gold nanoparticles inhibit amyloid aggregation of insulin , 2015, Amino Acids.

[37]  A. Haider,et al.  Preparation of Silver Nanoparticles and Their Industrial and Biomedical Applications: A Comprehensive Review , 2015 .

[38]  P. Eaton,et al.  Biochemical methods for monitoring protein thiol redox states in biological systems , 2014, Redox biology.

[39]  Nishant Verma,et al.  Synthesis and characterization of cysteine functionalized silver nanoparticles for biomolecule immobilization , 2014, Bioprocess and Biosystems Engineering.

[40]  E. Takai,et al.  Cysteine inhibits amyloid fibrillation of lysozyme and directs the formation of small worm‐like aggregates through non‐covalent interactions , 2014, Biotechnology progress.

[41]  V. Sim,et al.  D-amino acid-based peptide inhibitors as early or preventative therapy in Alzheimer disease , 2014, Prion.

[42]  A. Ulrich,et al.  Stereochemical effects on the aggregation and biological properties of the fibril-forming peptide [KIGAKI]3 in membranes. , 2013, Physical chemistry chemical physics : PCCP.

[43]  W. Qi,et al.  Physicochemical strategies for inhibition of amyloid fibril formation: an overview of recent advances. , 2012, Current medicinal chemistry.

[44]  Pedro J J Alvarez,et al.  Negligible particle-specific antibacterial activity of silver nanoparticles. , 2012, Nano letters.

[45]  J. Chipman,et al.  Silver and nanoparticles of silver in wound dressings: a review of efficacy and safety. , 2011, Journal of wound care.

[46]  Jason T. Stevens,et al.  Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation , 2011, Nature.

[47]  J. Weissman,et al.  Amyloid structure: conformational diversity and consequences. , 2011, Annual review of biochemistry.

[48]  M. Biancalana,et al.  Molecular mechanism of Thioflavin-T binding to amyloid fibrils. , 2010, Biochimica et biophysica acta.

[49]  Chia‐Hung Wu,et al.  Investigating the influences of redox buffer compositions on the amyloid fibrillogenesis of hen egg-white lysozyme. , 2009, Biochimica et biophysica acta.

[50]  Claire M. Cobley,et al.  Shape-Controlled Synthesis of Silver Nanoparticles for Plasmonic and Sensing Applications , 2009 .

[51]  Shuichi Yamamoto,et al.  Diseases of protein aggregation and the hunt for potential pharmacological agents , 2008, Biotechnology journal.

[52]  Wim Jiskoot,et al.  Extrinsic Fluorescent Dyes as Tools for Protein Characterization , 2008, Pharmaceutical Research.

[53]  M. Friedman.  Applications of the ninhydrin reaction for analysis of amino acids, peptides, and proteins to agricultural and biomedical sciences. , 2004, Journal of agricultural and food chemistry.

[54]  C. Verchere,et al.  Islet amyloid polypeptide and type 2 diabetes , 2003, Experimental Gerontology.

[55]  M. Pepys.  Pathogenesis, diagnosis and treatment of systemic amyloidosis. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[56]  B. S. Diwakar,et al.  Review on nanomaterials: Synthesis and applications , 2019, Materials Today: Proceedings.